Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Furst

Showing results (31-40 of 477) with videos related to

Pageof 48
Sort By:
Current Opinion in Rheumatology|April 23, 2003
Immunoglobulin for rheumatic diseases in the twenty-first century: take it or leave it?Yolanda Braun-Moscovici, Daniel E Furst
Rheumatic Diseases Clinics of North America|March 21, 2007
Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patientVeena K Ranganath, Daniel E Furst
Best Practice & Research. Clinical Rheumatology|December 11, 2007
Connective tissue diseasesDaniel E Furst, Marco Matucci Cerinic
Current Opinion in Rheumatology|April 23, 2003
Plasmapheresis for rheumatic diseases in the twenty-first century: take it or leave it?Yolanda Braun-Moscovici, Daniel E Furst
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 24, 2016
The Responsibilites of Daily Life May Interfere With Adherence to Medications in Patients With Rheumatoid Arthritis (RA) and Systemic Sclerosis (SSc)M Cameron Hay, Daniel E Furst
Arthritis and Rheumatism|April 13, 2004
Anti-tumor necrosis factor alpha therapy and heart failure: what have we learned and where do we go from here?Dinesh Khanna, Maureen McMahon, Daniel E Furst
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Meloxicam in rheumatoid arthritisMansoor Ahmed, Dinesh Khanna, Daniel E Furst
Lancet (London, England)|May 23, 2006
Systemic sclerosis: hypothesis-driven treatment strategiesChristina Charles, Philip Clements, Daniel E Furst
Drug Safety|April 6, 2004
Safety of tumour necrosis factor-alpha antagonistsDinesh Khanna, Maureen McMahon, Daniel E Furst
Expert Opinion on Biological Therapy|May 20, 2015
Brodalumab -an IL-17RA monoclonal antibody for psoriasis and psoriatic arthritisErin Bauer, Jessica Lucier, Daniel E Furst
Pageof 48

Showing results (31-40 of 477) with videos related to

Sort By:
Pageof 48
Current Opinion in Rheumatology|April 23, 2003
Immunoglobulin for rheumatic diseases in the twenty-first century: take it or leave it?Yolanda Braun-Moscovici, Daniel E Furst
Rheumatic Diseases Clinics of North America|March 21, 2007
Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patientVeena K Ranganath, Daniel E Furst
Best Practice & Research. Clinical Rheumatology|December 11, 2007
Connective tissue diseasesDaniel E Furst, Marco Matucci Cerinic
Current Opinion in Rheumatology|April 23, 2003
Plasmapheresis for rheumatic diseases in the twenty-first century: take it or leave it?Yolanda Braun-Moscovici, Daniel E Furst
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 24, 2016
The Responsibilites of Daily Life May Interfere With Adherence to Medications in Patients With Rheumatoid Arthritis (RA) and Systemic Sclerosis (SSc)M Cameron Hay, Daniel E Furst
Arthritis and Rheumatism|April 13, 2004
Anti-tumor necrosis factor alpha therapy and heart failure: what have we learned and where do we go from here?Dinesh Khanna, Maureen McMahon, Daniel E Furst
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Meloxicam in rheumatoid arthritisMansoor Ahmed, Dinesh Khanna, Daniel E Furst
Lancet (London, England)|May 23, 2006
Systemic sclerosis: hypothesis-driven treatment strategiesChristina Charles, Philip Clements, Daniel E Furst
Drug Safety|April 6, 2004
Safety of tumour necrosis factor-alpha antagonistsDinesh Khanna, Maureen McMahon, Daniel E Furst
Expert Opinion on Biological Therapy|May 20, 2015
Brodalumab -an IL-17RA monoclonal antibody for psoriasis and psoriatic arthritisErin Bauer, Jessica Lucier, Daniel E Furst
Pageof 48